𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders

✍ Scribed by Hanik K. Yoo; Joong-Sun Lee; Kyoung-Won Paik; Soon-Ho Choi; Sujung J. Yoon; Jieun E. Kim; Jin Pyo Hong

Publisher
Springer
Year
2010
Tongue
English
Weight
220 KB
Volume
20
Category
Article
ISSN
1018-8827

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The efficacy of reboxetine in the treatm
The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study
✍ P. N. Dannon; I. Iancu; L. Grunhaus πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 57 KB πŸ‘ 2 views

## Abstract ## Background and Objective Selective serotonin reuptake inhibitors (SSRIs) are currently the first‐line treatment for panic disorder, although up to 30% of patients either do not respond to SSRIs or withdraw due to adverse events. Reboxetine, a selective norepinephrine reuptake inhibi

Open-label flexible-dose pilot study to
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease
✍ Joseph H. Friedman; Robert M. Berman; Christopher G. Goetz; Stewart A. Factor; W πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 57 KB πŸ‘ 2 views

## Abstract Psychosis affects at least 5% to 8% of medication‐treated patients with idiopathic Parkinson's disease (PD). Treatment options include reducing medications used for the treatment of PD‐related motor symptoms or introducing an atypical antipsychotic drug. Only clozapine has been demonstr